Skip to main content
Premium Trial:

Request an Annual Quote

Finland s Chip-Man Raises 1.4M Euro to Develop Cell-Analysis Platform

NEW YORK, March 21 (GenomeWeb News) - Chip-Man Technologies, a Tampere, Finland-based developer of cellular analysis technology, said today that it has secured €1.4 million in first-round financing.

 

The company will use the funding, provided by Aura Capital and Finnish Industry Investment, to further develop its Cell-IQ cell analysis platform.

 

The company's Cell-IQ system monitors morphological and physiological changes in cell lines, primary cells, co-cultures, and monolayer tissue models in real time.

 

Chip-Man said that the market for automated cell analysis tools in pharmaceutical and medical research is estimated at around $500 million and is growing at 30 percent annually.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.